I Picked Up a Dimensional Travel Machine: Wizard - Chapter 54



Only Noblemtl
Read Novel Noblemtl

Is there magic on Earth? (1)
While we were having a natural conversation, I glanced at the ‘decorative sword’ hanging on the wall. Then, unable to overcome my curiosity, I asked a question.

“Excuse me….Father. I have a question.”

“Okay. Tell me. What are you curious about?”

“That old decorative sword hanging on the wall…anyway, that thing.”

“Yeah. But?”

“I’m a bit curious about how that sword was acquired. I’m a bit interested because it’s the first time I’ve seen it.”

“Ah. That sword was a gift from someone I know. There was someone who benefited greatly from me, if not his life. He said it was more valuable than it looks. I collect medieval antiques, but honestly, I’m not an expert, so I don’t know much about it. It’s just something that has a similar shape and atmosphere, so I just hung it up for decoration. Do you know anything about antiques like that?”

“Yes. I know quite a bit. Can I come closer and take a look?”

“It doesn’t matter.”

Min-ki got up from his seat and walked towards the wall.

If you look closely, you can see that it was a magic sword.

However, the magic sword’s magical function had already been stopped.

The biggest problem was that the space where the mana stone should have been was empty, and because too much time had passed or the magic circle had been partially erased due to rough use, it seemed that even if the mana stone was filled, the magic function would not be activated.

I muttered to myself and used component analysis and scanning magic to find out that it was indeed made using the magic of the other world (Maldek Central Continent).

Just a little bit. There was a very slight difference from the magic used these days, but it wasn’t a big difference.

The original engraved magic was a sword granted Sharpness and Hardness.

The problem was, ‘How does such an otherworldly magic sword exist on Earth?’

It was currently unknown whether there were beings like Min-gi who could travel across other worlds, or whether there was magic on Earth.

As they were examining the magic sword and pondering over it, Emilia’s father, Zachary Diaz, continued speaking.

“What’s wrong with the knife?”

“No. It’s a rare masterpiece. It’s a bit faded now because of the passage of time, but it must have been considered quite valuable when it was used a lot. I also have a hobby of collecting antiques. Do you happen to have more like this? Or can you introduce me to the person who gave it to me?”

“Really? Is it precious? I just put them here and there to decorate my room, so I don’t know the details. I honestly don’t know what’s precious and what’s common among the things here. So of course I don’t know if I can get more of those things. But if you need me, I can introduce you to the person who gave me that sword. What do you think? Ask him for more details.”

“Yes, thank you. Please introduce yourself. I’ve seen something interesting after a long time, and I’m interested.”

“Still, it’s better than hobbies like collecting odd-looking dolls, figures, etc.”

“Isn’t that the charm of antiques?”

“Oh, if you have the chance, I would like you to show me the antiques you have. Raising your standards is important for people like me who work in the tourism and hotel industry.”

“Yes. I’m still at a beginner level, but once I’ve collected a certain amount and organized it, I’ll definitely show it to my father.”

“Okay. Thank you.”

“Levi, I will now begin the summary report on the 2013 investment history.”

The Christmas party was over and the end of the year was approaching. Thanks to that, I was listening to the MF Invest annual settlement report. Today is the year-end settlement, so all the MF Invest executives including CEO Lewis, and even the CEO of MF Pharmaceuticals, Neomi Kale, were gathered.

“Yes. First, check MF Invest.”

“First, here is the current status of assets as of December 29, 2013. A total of 2.857 billion dollars (3.1427 trillion won).”

“Huh? It’s grown a lot more than I thought?”

“Yes. This massive Twitter IPO and listing has been a catalyst for exceeding the expected profits. The value at the end of August was $1.02 billion (KRW 1.122 trillion), but almost all of the listed stock investment amount, excluding venture investments previously invested in unlisted stocks, was used as collateral for stock-backed loans.

By using a total of $800 million (KRW 880 billion) for the Twitter IPO and initial stock trading, they achieved an average return of 260% over the IPO price and 185% over the initial public offering in about 49 days.

Thanks to this, I was able to make a total of $1.7 billion (1.87 trillion won) through Twitter IPO and stock investment. If you subtract the original $800 million, I made about $900 million (990 billion won) from Twitter alone. Now, I have sold all my Twitter stocks and do not have a single stock.

Thanks to you, we were able to far exceed our target rate of return. All of this was due to Levy’s foresight. Thank you.”

“There’s nothing to be thankful for. So are all your current assets invested in stocks?”

“That’s not it. Of course, most of it is invested in stocks and futures, but the total amount is 2.575 billion dollars (2 trillion 832.5 billion won). The rest is the amount of venture investment for the future that you previously instructed. That is, a total of 175 million dollars (192.5 billion won) for acquiring unlisted stocks, 5 million dollars (5.5 billion won) for purchasing a building, and 4 million dollars (4.4 billion won) for company operating expenses.

* * * * * * * * * * * * * *
* * Read Korean Novel * *
* * * Noblemtl dot com * * *
* * * * * * * * * * * * * *

The total amount is approximately $184 million (KRW 202.4 billion). This amount excludes approximately $100 million (KRW 110 billion) paid for the acquisition of MF Pharmaceuticals led by Rayzen, now Neomi Kale, and initial operating expenses. The asset value of MF Pharmaceuticals was fixed at the $100 million we paid, and we closed the accounting.”

“Is there no significant change in the stocks with the highest stock price increase rates that I mentioned and the total stock price indices such as NASDAQ?”

“There is a very small difference. It is still a very small difference. However, as our investment amount increases, the gap is gradually widening. However, it is still sufficient.”

“Good. It’s going smoothly. Thank you for your hard work in achieving excess profits. Next, report on MF Pharmaceuticals. Other things don’t matter, but first, how is the development of innovative antibiotics using Bagileon grass going?”

“The analysis of the ingredients that have already shown efficacy has been completed. This ingredient is a new substance that has not been discovered on Earth before. It seems that there will be no problem in mass production using chemical structural reactions. We have now passed the preclinical stage (animal testing). We have been conducting the final clinical trial on humans since last month.

However, based on the research so far, I think it will proceed without any major problems. Since it is mainly based on herbal ingredients, there were no problems with sampling. If everything goes as expected, I think it will be possible to launch it as a new drug in about 3 to 4 years.”

“Does FDA review take that long? 3-4 years?”

“Yes. This is a special item called antibiotics, so it is a figure that can be obtained quickly. A typical clinical trial usually takes 6 to 12 years.”

“Hmm… If everything goes smoothly, what are the expected sales?”

“It is expected to be around 4 billion dollars (4.4 trillion won) per year.”

“Wow. That’s a lot of money for just one new drug. Then what are the expected operating profits?”

“It’s $3.95 billion. Our MF Pharmaceuticals’ existing sales and administrative expenses were less than $30 million (KRW 33 billion). In addition, the gross profit for this new drug is so huge that it is analyzed that it will not even cost $20 million. In the end, as it is now, sales are almost the same as operating profit.

And this operating profit is the minimum. Our antibiotic is a completely new type of antibiotic that has never existed before. Therefore, it is completely effective against viruses and bacteria that are immune to existing antibiotics. In addition, it boasts excellent antibiotic performance.

Moreover, the most innovative thing is that since it is mainly composed of herbal ingredients, there are almost no side effects such as attacking normal cells. It is expected to be used as an antibiotic that is almost miraculous. If there are no major problems, it is expected to be worth about 20 billion dollars (22 trillion won) within 2-3 years after its release.”

“Wow. They say that one well-grown new drug is worth 100 generic drugs. That saying is exactly right.”

“Haha. This is all thanks to the ‘mysterious grass’ that Levy-sama gave me.”

“Anyway, please prepare thoroughly so that there are no problems with clinical trials and new drug applications and approvals.”

“all right.”

< >

“Chief, we’re in big trouble.”

“What? This is surprising. What’s going on?”

“A new antibiotic has been patented by a company called MF Pharmaceuticals.”

“What’s the problem? Is it a matter of one or two days to register a new antibiotic?”

“It’s a completely new compound. A new substance, a new class of antibiotics.”

“What? A new series?”

“Yes. It’s a completely new series that never existed before.”

“Is it really that important? To the point where you have to come running in and report it?”

“That’s it. This is a completely new series of discovery. It’s almost revolutionary. First of all, this ingredient is almost like a herbal ingredient. It’s not at the level of being made by simply modifying the chemical structure. On the contrary, it’s so excellent in structure and completion that it’s more like it was produced by chemically analyzing the herbal medicine. It seems like MF Pharmaceuticals has found a plant or ingredient that is the key to a new medicine in the remote areas of Africa or the jungle.”

“I still don’t quite understand. What’s the big deal?”

“Well. I think you don’t know much because you’ve only been in the supplement or auxiliary field and you’ve only recently come to the antibiotics department. Let me explain a little more. First of all, antibiotics started in the 1930s and 1940s. The famous penicillin was the first antibiotic. And after that, for about 20 years, many antibiotics were developed. However, no new antibiotics have been developed since the 1960s.”

“Why can’t we develop it? Just look at the number of researchers in our company. If we include other pharmaceutical companies, the number would be really huge.”

“First, antibiotics must find their antibacterial function. Depending on their function, the numerous types of antibiotics discovered or developed by humans ultimately fall into the following four categories: cell wall synthesis inhibition, protein synthesis inhibition, nucleic acid/folic acid metabolism inhibition, and cell membrane function inhibition.

Ah, of course, there are completely different methods, but their effectiveness and applicability are too limited, and their general usability is low. Anyway, from 1960 to around 2000, mankind failed to develop innovative new methods (series) of antibiotics. At best, they developed antibiotics of the existing method through modification of the chemical structure.

Of course, since 2000, recently, each pharmaceutical company has been developing new types of antibiotics with all their might, but even so, they are antibiotics that fall into the four categories. In addition, the emergence of ‘resistant bacteria’ that are resistant to antibiotics, which can be called the greatest enemy of antibiotics, is occurring very quickly.”

“Um. Okay. I understand. So?”

“The antibiotic developed by MF Pharmaceuticals this time is a completely new type of antibiotic that has never been heard of before. It is a new substance that is hard to say that it was discovered on Earth. And the application type is completely different. If you look at the data attached to the patent registration, there are probably dozens of derivative antibiotics of that type alone. It will serve as the root of the first antibiotic.

It is a completely new antibiotic with a different application method and fundamentals than existing antibiotics. Thanks to this, the FDA’s expectations are said to be sky-high. The analysis is not yet complete, but if it is as the patented content says, then if it is a completely new series of antibiotics, it can catch the unmet needs of resistant bacteria and Gram-negative super bacteria that have been a problem so far. This means that it can solve various problems in the existing antibiotic market at once. In other words, I think the impact on the antibiotic market will be enormous.”

“Really? This is a problem, just as you said. What is the current status of development?”

“Yes. It is said that Phase 1 clinical trials are currently underway with the FDA. However, rumor has it that Phase 1 trials are almost perfect and stable. If this continues, it seems that they will soon enter Phase 2 clinical trials. Oh~! Of course, the patent rights for the active ingredients have been completed.”

“Is there any patent infringement on our antibiotics? Is there anything that can be taken as a stepping stone? If it is as you say, it will have a huge impact on our product sales. Can’t we just stand by and watch?”

Read Novel Noblemtl
Read Novel Noblemtl